Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 299

1.

Choroidal neovascularization associated with focal choroidal excavation.

Lee JH, Lee WK.

Am J Ophthalmol. 2014 Mar;157(3):710-8.e1. doi: 10.1016/j.ajo.2013.12.011. Epub 2013 Dec 15.

PMID:
24345322
2.

Focal choroidal excavation complicated by choroidal neovascularization.

Xu H, Zeng F, Shi D, Sun X, Chen X, Bai Y.

Ophthalmology. 2014 Jan;121(1):246-50. doi: 10.1016/j.ophtha.2013.08.014. Epub 2013 Oct 4.

PMID:
24095605
3.

Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation.

Lee CS, Woo SJ, Kim YK, Hwang DJ, Kang HM, Kim H, Lee SC.

Ophthalmology. 2014 May;121(5):1029-35. doi: 10.1016/j.ophtha.2013.11.043. Epub 2014 Jan 16.

PMID:
24439757
4.

Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy.

Punjabi OS, Huang J, Rodriguez L, Lyon AT, Jampol LM, Mirza RG.

Br J Ophthalmol. 2013 Aug;97(8):1024-31. doi: 10.1136/bjophthalmol-2013-303155. Epub 2013 Jun 12.

PMID:
23759437
5.

Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.

el Matri L, Chebil A, Kort F, Bouraoui R, Baklouti K, Mghaieth F.

Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):779-84. doi: 10.1007/s00417-010-1302-4. Epub 2010 Feb 19.

PMID:
20169357
6.

Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.

Nagiel A, Freund KB, Spaide RF, Munch IC, Larsen M, Sarraf D.

Am J Ophthalmol. 2013 Nov;156(5):981-988.e2. doi: 10.1016/j.ajo.2013.06.024. Epub 2013 Aug 20.

PMID:
23972309
7.

Characteristic spectral-domain optical coherence tomography findings of multifocal choroiditis.

Vance SK, Khan S, Klancnik JM, Freund KB.

Retina. 2011 Apr;31(4):717-23. doi: 10.1097/IAE.0b013e318203c1ef.

PMID:
21386760
8.
9.

Near-infrared autofluorescence in patients with idiopathic submacular choroidal neovascularization.

Toju R, Iida T, Sekiryu T, Saito M, Maruko I, Kano M.

Am J Ophthalmol. 2012 Feb;153(2):314-9. doi: 10.1016/j.ajo.2011.06.026. Epub 2011 Oct 8.

PMID:
21982958
10.

Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.

Yoon JU, Kim YM, Lee SJ, Byun YJ, Koh HJ.

Retina. 2012 May;32(5):949-55. doi: 10.1097/IAE.0b013e318227a9ef.

PMID:
22534553
11.

Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up.

Costagliola C, Semeraro F, Cipollone U, Rinaldi M, della Corte M, Romano MR.

Graefes Arch Clin Exp Ophthalmol. 2009 Aug;247(8):1031-7. doi: 10.1007/s00417-009-1081-y. Epub 2009 Apr 29.

PMID:
19404665
12.

The expanded spectrum of focal choroidal excavation.

Margolis R, Mukkamala SK, Jampol LM, Spaide RF, Ober MD, Sorenson JA, Gentile RC, Miller JA, Sherman J, Freund KB.

Arch Ophthalmol. 2011 Oct;129(10):1320-5. doi: 10.1001/archophthalmol.2011.148. Epub 2011 Jun 13.

PMID:
21670327
13.

Choroidal naevi complicated by choroidal neovascular membrane and outer retinal tubulation.

Papastefanou VP, Nogueira V, Hay G, Andrews RM, Harris M, Cohen VM, Sagoo MS.

Br J Ophthalmol. 2013 Aug;97(8):1014-9. doi: 10.1136/bjophthalmol-2013-303234. Epub 2013 May 18.

PMID:
23686326
14.

Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.

Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N.

Retina. 2011 May;31(5):871-9. doi: 10.1097/IAE.0b013e3182003ca8.

PMID:
21358461
15.

Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.

Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C.

Acta Ophthalmol. 2009 Jun;87(4):404-7. doi: 10.1111/j.1755-3768.2008.01262.x. Epub 2008 Sep 8.

16.

Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients.

Suzuki M, Gomi F, Sawa M, Tsujikawa M, Sakaguchi H.

Jpn J Ophthalmol. 2010 Mar;54(2):124-8. doi: 10.1007/s10384-009-0775-3. Epub 2010 Apr 18.

PMID:
20401560
17.

Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.

Mimoun G, Caillaux V, Querques G, Rothschild PR, Puche N, Souied EH.

Retina. 2013 Mar;33(3):513-21. doi: 10.1097/IAE.0b013e3182753adb.

PMID:
23400081
18.

Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.

Freeman WR, Kozak I, Yuson RM, Nigam N, Cheng L, Mojana F.

Retina. 2011 Oct;31(9):1812-8. doi: 10.1097/IAE.0b013e31821987a4.

PMID:
21866073
19.

Supplemental Content

Support Center